Ajooni Biotech Limited — Important, 18-02-2025: Updates

Ajooni Biotech Limited has affirmed that Mr. Ishtneet Singh Bhatia, the newly appointed Independent Director, is not debarred from holding office in accordance with any SEBI order or other authority. This confirmation follows an earlier update regarding his appointment and aligns with the compliance requirements set out by the NSE. The affirmation ensures transparency in the appointment process and adherence to regulatory standards, reflecting positively on the company’s governance practices. This development may bolster investor confidence in the company's leadership structure as it continues to navigate its strategic directions.